Inventor

DUBE MARIE-PIERRE

CA9 patents

⚠️ This page may combine multiple inventors who share the name “DUBE MARIE-PIERRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

6 patents

US9909178B2Mar 6, 2018

Dalcetrapib for therapeutic use

HOFFMANN LA ROCHE5 citations80

US11401554B2Aug 2, 2022

Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent

HOFFMANN LA ROCHE1 citations71

US10584385B2Mar 10, 2020

Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent

HOFFMANN LA ROCHE3 citations71

US10711303B2Jul 14, 2020

CETP inhibitors for therapeutic use

HOFFMANN LA ROCHE3 citations69

US12371748B2Jul 29, 2025

Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent

HOFFMANN LA ROCHE0 citations60

US11549142B2Jan 10, 2023

CETP inhibitors for therapeutic use

HOFFMANN LA ROCHE0 citations58

BESSETTE LUC

1 patent

US7734656B2Jun 8, 2010

System and method for electronically managing medical data files in order to facilitate genetic research

BESSETTE LUC37 citations94

DUBE MARIE-PIERRE

1 patent

US8563241B2Oct 22, 2013

Genetic predictors of international normalized ratio (INR) fluctuation with warfarin therapy

DUBE MARIE-PIERRE0 citations34

SAMUELS MARK ELLIOT

1 patent

US8334369B2Dec 18, 2012

Mutations in human UBIAD1

SAMUELS MARK ELLIOT0 citations30